Northwind Pharmaceuticals

Northwind Hiring Warehouse & Packaging Personnel

Due to rapid growth, we are looking to add Associates to help our fulfillment organization.

Responsibilities include: receiving, shipping, pick and pack, kitting, labeling

Work Experience: 2-5 years in a warehouse environment

Key Skills:

  • Attention to detail
  • Ability to key data into a computer
  • Ability to lift 25lbs
  • Fast learner

Critical Attributes:

  • Reliable
  • Strong communications skills
  • Self-starter
  • Flexible
  • Team player

Education: High School Diploma

Other details:

  • Full time position
  • Pay Rate: $12-$15/hour
  • Health benefits
  • Hiring immediately

Job Type: Full-time

Job Type: Full-time

Job Location:

  • Indianapolis, IN 46256

Required education:

  • High school or equivalent

Required experience:

  • warehouse or packaging: 2+ years

Click here to apply

 

Schedule a free claims analysis now.

Let’s Talk now

Leader in AI-driven health benefits navigation Healthee partners with Northwind

Katherine Lurk | Mar 28th, 2025
A game-changer for employers looking to cut costs and gain control With healthcare costs continuing to rise, employers are seeking new ways to rein in spending without sacrificing the quality of benefits. This partnership enables Healthee clients to optimize prescription drug management, reducing costs through preferable generic drug pricing, high-touch chronic care programs, and more. … more »

continue reading

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading